Exceptional Sustained Responses To Ipilimumab/Nivolumab (Ipi/Nivo) In Patients (Pts) With Advanced Pancreaticobiliary Cancers And Germline Dna Damage Repair (Ddr) Mutations.
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要